Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 76420-812

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 76420-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Bupropion Hydrochloride. (Image 1)

Chemical structure diagram of Bupropion Hydrochloride showing the arrangement of its molecular components, including a chlorinated phenyl ring and tertiary butyl group, and the presence of hydrochloride (HCl).*

FDA Label Image

1 (Image 2)

Labels for Bupropion Hydrochloride extended release tablets, USP 300 mg by Asclemed USA, Inc., show various National Drug Codes (NDCs) for different package sizes ranging from 30 to 500 tablets. Labels include package and relabel information, batch and lot details, barcodes, storage instructions, and cautionary statements with a consistent design featuring the Enovachem Pharmaceuticals logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.